chloroquine has been researched along with Cardiac Rupture, Traumatic in 2 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We found no increased risk of ischemic heart injury or heart failure as a result of administering chloroquine." | 8.02 | No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not. ( Beck-Friis, J; Gisslen, M; Leach, S; Omerovic, E; Yilmaz, A; Zeijlon, R, 2021) |
| "We found no increased risk of ischemic heart injury or heart failure as a result of administering chloroquine." | 4.02 | No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not. ( Beck-Friis, J; Gisslen, M; Leach, S; Omerovic, E; Yilmaz, A; Zeijlon, R, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck-Friis, J | 1 |
| Leach, S | 1 |
| Omerovic, E | 1 |
| Zeijlon, R | 1 |
| Gisslen, M | 1 |
| Yilmaz, A | 1 |
| Unuma, K | 1 |
| Aki, T | 1 |
| Funakoshi, T | 1 |
| Yoshida, K | 1 |
| Uemura, K | 1 |
2 other studies available for chloroquine and Cardiac Rupture, Traumatic
| Article | Year |
|---|---|
No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not.
Topics: Aged; Antiviral Agents; Biomarkers; C-Reactive Protein; Case-Control Studies; Chloroquine; COVID-19; | 2021 |
Cobalt protoporphyrin accelerates TFEB activation and lysosome reformation during LPS-induced septic insults in the rat heart.
Topics: Animals; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Nucleus; Chlor | 2013 |